838 related articles for article (PubMed ID: 31269763)
1. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.
Koneczny I; Herbst R
Cells; 2019 Jul; 8(7):. PubMed ID: 31269763
[TBL] [Abstract][Full Text] [Related]
2. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
Pevzner A; Schoser B; Peters K; Cosma NC; Karakatsani A; Schalke B; Melms A; Kröger S
J Neurol; 2012 Mar; 259(3):427-35. PubMed ID: 21814823
[TBL] [Abstract][Full Text] [Related]
3. [Autoantibodies in myasthenia gravis].
Motomura M; Narita Masuda T
Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
[TBL] [Abstract][Full Text] [Related]
4. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
Ohta R; Motomura M
Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to agrin in myasthenia gravis patients.
Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
[TBL] [Abstract][Full Text] [Related]
6. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
7. Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis.
Yan M; Xing GL; Xiong WC; Mei L
Ann N Y Acad Sci; 2018 Feb; 1413(1):126-135. PubMed ID: 29377176
[TBL] [Abstract][Full Text] [Related]
8. Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice.
Yan M; Liu Z; Fei E; Chen W; Lai X; Luo B; Chen P; Jing H; Pan JX; Rivner MH; Xiong WC; Mei L
Neuroscience; 2018 Mar; 373():113-121. PubMed ID: 29339325
[TBL] [Abstract][Full Text] [Related]
9. MuSK antibodies, lessons learned from poly- and monoclonality.
Vergoossen DLE; Augustinus R; Huijbers MG
J Autoimmun; 2020 Aug; 112():102488. PubMed ID: 32505442
[TBL] [Abstract][Full Text] [Related]
10. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.
Shen C; Lu Y; Zhang B; Figueiredo D; Bean J; Jung J; Wu H; Barik A; Yin DM; Xiong WC; Mei L
J Clin Invest; 2013 Dec; 123(12):5190-202. PubMed ID: 24200689
[TBL] [Abstract][Full Text] [Related]
12. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
[TBL] [Abstract][Full Text] [Related]
13. Anti-agrin autoantibodies in myasthenia gravis.
Gasperi C; Melms A; Schoser B; Zhang Y; Meltoranta J; Risson V; Schaeffer L; Schalke B; Kröger S
Neurology; 2014 Jun; 82(22):1976-83. PubMed ID: 24793185
[TBL] [Abstract][Full Text] [Related]
14. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.
Huijbers MG; Zhang W; Klooster R; Niks EH; Friese MB; Straasheijm KR; Thijssen PE; Vrolijk H; Plomp JJ; Vogels P; Losen M; Van der Maarel SM; Burden SJ; Verschuuren JJ
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20783-8. PubMed ID: 24297891
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis experimentally induced with muscle-specific kinase.
Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
[TBL] [Abstract][Full Text] [Related]
16. Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.
Cenacchi G; Papa V; Fanin M; Pegoraro E; Angelini C
J Neurol; 2011 May; 258(5):746-52. PubMed ID: 21088848
[TBL] [Abstract][Full Text] [Related]
17. Induction of myasthenia by immunization against muscle-specific kinase.
Shigemoto K; Kubo S; Maruyama N; Hato N; Yamada H; Jie C; Kobayashi N; Mominoki K; Abe Y; Ueda N; Matsuda S
J Clin Invest; 2006 Apr; 116(4):1016-24. PubMed ID: 16557298
[TBL] [Abstract][Full Text] [Related]
18. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
[TBL] [Abstract][Full Text] [Related]
19. The auto-antigen repertoire in myasthenia gravis.
Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
[TBL] [Abstract][Full Text] [Related]
20. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
Koneczny I; Cossins J; Vincent A
J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
